A phase I study of the histone deacetylase (HDAC) inhibitor PXD101 in patients with advanced hematological tumors

被引：0
|
作者：
Hansen, M
Gimsing, P
Rasmussen, A
Jensen, PB
Knudsen, LM
机构：
[1] Rigshosp, DK-2100 Copenhagen, Denmark
[2] Topotarget AS, Copenhagen, Denmark
[3] Herlev Univ Hosp, Copenhagen, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225S / 225S
页数：1
相关论文
共 50 条
  • [21] The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines
    Ma, Brigette B. Y.
    Sung, Fion
    Tao, Qian
    Poon, Fan Fong
    Lui, Vivian W.
    Yeo, Winnie
    Chan, Stephen L.
    Chan, Anthony T. C.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (02) : 107 - 114
  • [22] A phase I study of oral administration of the histone deacetylase (HDAC) inhibitor belinostat in patients (pts) with advanced solid tumors
    Kelly, W.
    Petrylak, D.
    Blumenschein, G.
    Lassen, U.
    Jensen, P. Buhl
    DeBono, J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 127 - 127
  • [23] The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines
    Brigette B.Y. Ma
    Fion Sung
    Qian Tao
    Fan Fong Poon
    Vivian W. Lui
    Winnie Yeo
    Stephen L. Chan
    Anthony T.C. Chan
    Investigational New Drugs, 2010, 28 : 107 - 114
  • [24] A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors and lymphoma
    O'Bryant, Cindy L.
    Leong, Stephen
    Camidge, D. Ross
    Gore, Lia
    Diab, Sami
    Gustafson, Dan L.
    Call, Justin
    Spratlin, Jennifer
    Zwiebel, James A.
    Eckhardt, S. Gail
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3384S - 3384S
  • [25] A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors or lymphoma
    Nallapareddy, Sujatha
    Leong, Stephen
    Camidge, Ross
    Gore, Lia
    Diab, Sami
    Messersmith, Wells
    Lewis, Karl
    Weekes, Colin
    Gustafson, Daniel
    Jimeno, Antonio
    Zwiebel, James
    -Delgado, Igor Espinoza
    Eckhardt, Gail
    O'Bryant, Cindy
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [26] The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models
    Na, Young-Soon
    Jung, Kyung-Ah
    Kim, Seung-Mi
    Hong, Yong Sang
    Ryu, Min-Hee
    Jang, Se Jin
    Moon, Dae Hyuk
    Cho, Dong-Hyung
    Kim, Jin Cheon
    Lee, Jung Shin
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 389 - 398
  • [27] ASSESSING TREATMENT RESPONSE OF GLIOBLASTOMA TO AN HDAC INHIBITOR, BELINOSTAT (PXD101)
    Gurbani, Saumya
    Sengupta, Soma
    Voloschin, Alfredo
    Liang, Zhongxing
    Yoon, Younghyoun
    Vega, Jose Enrique Velazquez
    Holder, Chad A.
    Olson, Jeffrey J.
    Shu, Hui-Kuo
    Shim, Hyunsuk
    NEURO-ONCOLOGY, 2017, 19 : 148 - 148
  • [28] The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
    Buckley, Michael T.
    Yoon, Joanne
    Yee, Herman
    Chiriboga, Luis
    Liebes, Leonard
    Ara, Gulshan
    Qian, Xiaozhong
    Bajorin, Dean F.
    Sun, Tung-Tien
    Wu, Xue-Ru
    Osman, Iman
    JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)
  • [29] Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101
    Plumb, JA
    Finn, PW
    Williams, RJ
    Bandara, MJ
    Romero, MR
    Watkins, CJ
    La Thangue, NB
    Brown, R
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (08) : 721 - 728
  • [30] The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models
    Young-Soon Na
    Kyung-Ah Jung
    Seung-Mi Kim
    Yong Sang Hong
    Min-Hee Ryu
    Se Jin Jang
    Dae Hyuk Moon
    Dong-Hyung Cho
    Jin Cheon Kim
    Jung Shin Lee
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 389 - 398
12345